Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo

References

• XuYZhuYShenZSignificance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapyEndocrine201140344545121706269
   PubMed Web of Science ®Google Scholar
• O’SullivanCEdgerlyMVelardeMThe VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancerJ Clin Endocrinol Metab20149941291129724423320
   PubMed Web of Science ®Google Scholar
• TerzoloMZaggiaBAllasinoBDe FranciaSPractical treatment using mitotane for adrenocortical carcinomaCurr Opin Endocrinol Diabetes Obes201421315916524732405
   PubMed Web of Science ®Google Scholar
• GermanoARapaIVolanteMCytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell linesMol Cell Endocrinol201438211724018612
   PubMed Web of Science ®Google Scholar
• GloverARZhaoJTGillAJMicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaOncotarget2015634366753668826452132
   PubMedGoogle Scholar
• DemeureMJStephanESinariSPreclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancerAnn Surg2012255114014622156929
   PubMed Web of Science ®Google Scholar
• SubramanianCKuaiRZhuQSynthetic high-density lipoprotein nanoparticles: a novel therapeutic strategy for adrenocortical carcinomasSurgery2016159128429526582501
   PubMed Web of Science ®Google Scholar
• HantelCJungSMussackTReinckeMBeuschleinFLiposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent modelEndocr Relat Cancer201421338339424532475
   PubMed Web of Science ®Google Scholar
• XinYLiuTYangCDevelopment of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug deliveryInt J Nanomedicine2016115807582127853366
   PubMed Web of Science ®Google Scholar
• GwakHRKimSDhanasekaranDNSongYSResveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cellsCancer Lett2016371234735326704305
   PubMed Web of Science ®Google Scholar
• GurunathanSHanJWKimESParkJHKimJHReduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic moleculeInt J Nanomedicine2015102951296925931821
   PubMed Web of Science ®Google Scholar
• JayaprakashaGKMurthyKNCPatilBSEnhanced colon cancer chemoprevention of curcumin by nanoencapsulation with whey proteinEur J Pharmacol201678929130027404761
   PubMed Web of Science ®Google Scholar
• WangDZhouJChenRControllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapyBiomaterials2016100274027240160
   PubMed Web of Science ®Google Scholar
• KoudelkaŠTuránekJLiposomal paclitaxel formulationsJ Control Release2012163332233422989535
   PubMed Web of Science ®Google Scholar
• ZhuMLiWLuYAlpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitroSci Rep201662647227255186
   PubMed Web of Science ®Google Scholar
• GellerMACooleySJudsonPLA phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerCytotherapy20111319810720849361
   PubMed Web of Science ®Google Scholar
• BradleyJDPaulusRKomakiRStandard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyLancet Oncol201516218719925601342
   PubMed Web of Science ®Google Scholar
• BerrutiASperonePFerreroAPhase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinomaEur J Endocrinol2012166345145822189997
   PubMed Web of Science ®Google Scholar
• XiaoKLuoJFowlerWLA self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials200930306006601619660809
   PubMed Web of Science ®Google Scholar
• ZhangCLuTTaoJWanGZhaoHCo-delivery of paclitaxel and indocyanine green by PEGylated graphene oxide: a potential integrated nanoplatform for tumor theranosticsRSC Adv20166191546015468
   Web of Science ®Google Scholar
• GogatéUSSchwartzPAAgharkarSNEffect of unpurified Cremophor EL on the solution stability of paclitaxelPharm Dev Technol20091411818791935
   PubMed Web of Science ®Google Scholar
• KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release200172119120211389998
   PubMed Web of Science ®Google Scholar
• AngelopoulouAVoulgariEDiamantiEKGournisDAvgoustakisKGraphene oxide stabilized by PLA–PEG copolymers for the controlled delivery of paclitaxelEur J Pharm Biopharm201593182625817600
   PubMed Web of Science ®Google Scholar
• KinoshitaRIshimaYChuangVTGImproved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimerBiomaterials201714016216928651144
   PubMed Web of Science ®Google Scholar
• RuttalaHBKoYTLiposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacyPharm Res20153231002101625213777
   PubMed Web of Science ®Google Scholar
• ZhangWGuoZHuangDLiuZGuoXZhongHSynergistic effect of chemo-photothermal therapy using PEGylated graphene oxideBiomaterials201132338555856121839507
   PubMed Web of Science ®Google Scholar
• ChungCKimYKShinDRyooSHongBMinDBiomedical applications of graphene and graphene oxideAcc Chem Res201346102211222423480658
   PubMed Web of Science ®Google Scholar
• LiuZRobinsonJTSunXDaiHPEGylated nanographene oxide for delivery of water-insoluble cancer drugsJ Am Chem Soc200813033108761087718661992
   PubMed Web of Science ®Google Scholar
• ChenJLiuCZengGIndocyanine green loaded reduced graphene oxide for in vivo photoacoustic/fluorescence dual-modality tumor imagingNanoscale Res Lett20161118526868422
   PubMedGoogle Scholar
• WangYWFuYYPengQDye-enhanced graphene oxide for photothermal therapy and photoacoustic imagingJ Mater Chem B201314257625767
   PubMed Web of Science ®Google Scholar
• YangXZhangXMaYHuangYWangYChenYSuperparamagnetic graphene oxide–Fe3O4 nanoparticles hybrid for controlled targeted drug carriersJ Mater Chem2009191827102714
   Web of Science ®Google Scholar
• KurapatiRRaichurAMNear-infrared light-responsive graphene oxide composite multilayer capsules: a novel route for remote controlled drug deliveryChem Commun2013497734736
   PubMed Web of Science ®Google Scholar
• MuthoosamyKAbubakarIBBaiRGLohHSManickamSExceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatmentSci Rep201663280827597657
   PubMed Web of Science ®Google Scholar
• KimHLeeDKimJKimTIKimWJPhotothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxideACS Nano2013786735674623829596
   PubMed Web of Science ®Google Scholar
• HuWPengCLvMProtein corona-mediated mitigation of cytotoxicity of graphene oxideACS Nano2011553693370021500856
   PubMed Web of Science ®Google Scholar
• SarfrazMAfzalARazaSMLiposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinomaOncotarget2017829471364715328525367
   PubMedGoogle Scholar
• AkashMSRehmanKChenSPolymeric-based particulate systems for delivery of therapeutic proteinsPharm Dev Technol201621336737825567454
   PubMed Web of Science ®Google Scholar
• MaCShiYPenaDAPengLYuGThermally responsive hydrogel blends: a general drug carrier model for controlled drug releaseAngew Chem Int Ed Engl20151272574847488
   Google Scholar
• YuZYuMZhangZHongGXiongQBovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner earNanoscale Res Lett20149134325114637
   PubMed Web of Science ®Google Scholar
• GengTZhaoXMaMZhuGYinLResveratrol-loaded albumin nanoparticles with prolonged blood circulation and improved bio-compatibility for highly effective targeted pancreatic tumor therapyNanoscale Res Lett201712143728673056
   PubMedGoogle Scholar
• ZongYWuJShenKNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisOncotarget2017810173601737228061451
   PubMedGoogle Scholar
• QuNLeeRJSunYCabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancerInt J Nanomedicine2016113451345927555767
   PubMed Web of Science ®Google Scholar
• HanYShchukinDYangJSimonCRFuchsHMöhwaldHBio-compatible protein nanocontainers for controlled drugs releaseACS Nano2010452838284420394391
   PubMed Web of Science ®Google Scholar
• RobinsonJTWelsherKTabakmanSMHigh performance in vivo near-IR (.1 μm) imaging and photothermal cancer therapy with carbon nanotubesNano Res201031177979321804931
   PubMed Web of Science ®Google Scholar
• YangQJonesSWParkerCLZamboniWCBearJELaiSKEvading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformationMol Pharm20141141250125824521246
   PubMed Web of Science ®Google Scholar
• DuanXLiYPhysicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and traffickingSmall201399–101521153223019091
   PubMed Web of Science ®Google Scholar
• AbakumovMANukolovaNVSokolsky-PapkovMVEGF-targeted magnetic nanoparticles for MRI visualization of brain tumorNanomedicine201511482583325652902
   PubMed Web of Science ®Google Scholar